组织工程与重建外科杂志 ›› 2022, Vol. 18 ›› Issue (3): 227-.

• • 上一篇    下一篇

CO2点阵激光结合丝素蛋白载积雪草苷水凝胶治疗兔耳增生性瘢痕的实验研究

  

  • 出版日期:2022-06-01 发布日期:2022-07-11

Treatment of rabbit ear hypertrophic scar by CO2 fractional laser-assisted silk nanofiber hydrogel-loaded asiaticoside 

  • Online:2022-06-01 Published:2022-07-11

摘要: 目的 评估丝素蛋白水凝胶作为一种药物载体的可行性,以及CO2点阵激光协同丝素蛋白载积雪草苷水凝胶(SNF-AC)对兔耳增生性瘢痕的治疗效果。方法 制备SNF-AC并表征;构建兔耳增生性瘢痕模型,按治疗方法不同进行分组:① L+SNF-AC组,CO2点阵激光+涂抹SNF-AC;②L组,CO2点阵激光;③SNF-AC组,涂抹SNF-AC;④空白对照组(Control组)。治疗后第7、14天,测量增生性瘢痕厚度,评价血管分布,HE染色观察组织学形态,Masson染色观察胶原纤维排列。结果 SNF-AC与丝素蛋白的表面形貌和流变学行为相似,拉曼光谱特征峰显示丝素蛋白可成功加载积雪草苷。治疗后第7天,瘢痕相对厚度变化值L+SNF-AC组>L组>SNF-AC组>Control组,且L+SNF-AC组、L组和Control组差异有统计学意义。治疗后第14天,L+SNF-AC组瘢痕相对厚度变化值高于其他3组,但各组之间无统计学差异。治疗后第7、14天,L+SNF-AC组血管分布评分显著优于其余3组(P<0.05)。治疗后第14天,HE染色显示L+SNF-AC组增生性瘢痕表面趋于平整,而其余3组增生性瘢痕表面均有不同程度凸起;Masson染色显示L+SNF-AC组和L组的胶原纤维排列整齐,接近正常皮肤,而SNF-AC组和Control组胶原排列紊乱。结论 丝素蛋白水凝胶可作为抗瘢痕药物积雪草苷的有效载体,CO2点阵激光协同SNF-AC有助于降低增生性瘢痕厚度,减少增生性瘢痕的血管分布,是一种有效的增生性瘢痕治疗方法。

关键词: 丝素蛋白水凝胶,  激光辅助透皮给药,  CO2点阵激光,  增生性瘢痕

Abstract: Objective To investigate the feasibility of silk nanofiber hydrogel (SNF) as drug carrier and the efficacy of silk nanofiber hydrogel-loaded asiaticoside(SNF-AC) combined with CO2 fractional laser in the treatment of hypertrophic scar. Methods SNF-AC was prepared and characterized. Then, the rabbit ear hypertrophic scar model was constructed in vivo, and intervention was performed as follows: ①CO2 fractional laser combined with SNF-AC (L+SNF-AC group); ②CO2 fractional laser(L group) ③SNF-AC (SNF-AC group); ④blank control group(Control group). On day 7 and 14 after intervention, the thickness of hypertrophic scar was measured, the vascularity was evaluated, the histological morphology was observed by HE staining, and the arrangement of collagen fibers was observed by Masson staining. Results The surface morphology and rheological behavior of SNF-AC were similar to that of silk nanofiber hydrogel, and the characteristic peak of Raman spectrum showed that asiaticoside could be successfully loaded into SNF. The relative thickness change value was L+SNF-AC group > L group > SNF-AC group > Control group on the 7th day after treatment. The difference between the L+SNF-AC group and the Control group was statistically significant, as well as the difference between the L group and the Control group. On the 14th day after treatment, the relative thickness change of L+SNF-AC group was higher than that of the other three groups, but there was no statistical difference among the groups. No matter on day 7 or day 14 after treatment, the vascularity change in L+SNF-AC group was significantly better than that in the other three groups, with statistical differences. HE staining of hypertrophic scar showed that on the 14th day after treatment, the surface of hypertrophic scar tended to be flat in the L+SNF-AC group, while the surface of hypertrophic scar in the other three groups were raised to varying degrees. Masson staining results showed that on the 14th day after treatment, collagen fibers in L+SNF-AC group and L group were flat and tended to normal tissue, while collagen fibers in SNF-AC group and Control group were disordered. Conclusion SNF is suitable as a drug carrier for hypertrophic scar. And CO2 fractional laser combined with SNF-AC can reduce the thickness of hypertrophic scar and improve the vascular distribution of hypertrophic scar, which is an effective scar treatment method.

Key words: Silk nanofiber hydrogels,  Laser-assisted transdermal drug delivery,  CO2 fractional laser,  Hypertrophic scar